Related Experiment Video
Updated: Apr 5, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Important causes of chronic kidney disease in South Africa
M R Moosa1, I Van der Walt, S Naicker
1Division of Nephrology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa. rmm@sun.ac.za.
Insights
Hypertensive patients with chronic kidney disease (CKD) require stricter blood pressure control (≤130/80 mmHg), especially with proteinuria. Careful monitoring of medications like ACE inhibitors and ARBs is crucial for managing kidney function and preventing complications.
Area of Science:
- Nephrology
- Cardiology
- Infectious Diseases
Background:
- Hypertension management differs significantly in patients with and without chronic kidney disease (CKD).
- Proteinuria is a key factor in determining blood pressure (BP) targets for CKD patients.
- HIV infection presents a complex spectrum of renal complications.
Purpose of the Study:
- To outline current guidelines for managing hypertension in patients with CKD.
- To highlight specific considerations for medication use in advanced CKD stages.
- To review the renal manifestations of HIV infection and its treatment.
Main Methods:
- Review of existing clinical guidelines and literature on hypertension and CKD management.
- Analysis of recommendations for antihypertensive and antidiabetic medications in CKD.
- Summary of renal complications associated with HIV infection and antiretroviral therapy.
Main Results:
- Target BP for hypertensive patients with CKD and proteinuria (≥0.5 g/day) is ≤130/80 mmHg.
- Lifestyle modifications (low salt, adequate potassium, weight control) are essential.
- Caution is advised with ACE inhibitors/ARBs in advanced CKD (stages 4-5), particularly in older patients with diabetes or atherosclerosis, due to hyperkalemia risk.
- Metformin is contraindicated in stages 4-5 CKD.
- HIV infection can lead to various kidney issues, including acute kidney injury and HIV-associated nephropathy.
Conclusions:
- Stricter BP control and careful medication management are vital for hypertensive patients with CKD.
- Regular monitoring and home BP measurement are recommended for optimal management.
- Understanding the diverse renal effects of HIV is critical for patient care.
Abstract:
In hypertensive patients without chronic kidney disease (CKD) the goal is to keep blood pressure (BP) at ≤140/90 mmHg. When CKD ispresent, especially where there is proteinuria of ≥0.5 g/day, the goal is a BP of ≤130/80 mmHg. Lifestyle measures are mandatory, especiallylimitation of salt intake, ingestion of adequate quantities of potassium, and weight control. Patients with stages 4 - 5 CKD must be carefullymonitored for hyperkalaemia and deteriorating kidney function if angiotensin-converting enzyme (ACE) inhibitors or angiotensin IIreceptor blockers (ARBs) are used, especially in patients >60 years of age with diabetes or atherosclerosis. BP should be regularly monitoredand, where possible, home BP-measuring devices are recommended for optimal control.Guidelines on the use of antidiabetic agents in CKD are presented, with the warning that metformin is contraindicated in patients withstages 4 - 5 CKD.There is a wide clinical spectrum of renal disease in the course of HIV infection, including acute kidney injury, electrolyte and acid-basedisturbances, HIV-associated glomerular disease, acute-on-chronic renal disease and side-effects related to the treatment of HIV.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury I: Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology

